guanabenz has been researched along with Peripheral Nervous System Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertozzi, F; Gardell, LR; Gaubert, G; Kelly, NM; Lameh, J; Nash, NR; Olsson, R; Pawlas, J; Scully, AL | 1 |
Jevtovic-Todorovic, V; Meyenburg, AP; Olney, JW; Wozniak, DF | 1 |
2 other study(ies) available for guanabenz and Peripheral Nervous System Diseases
Article | Year |
---|---|
Discovery of selective nonpeptidergic neuropeptide FF2 receptor agonists.
Topics: Analgesics; Animals; Carrageenan; Guanidines; Humans; In Vitro Techniques; Inflammation; Microsomes, Liver; Pain; Pain Measurement; Peripheral Nervous System Diseases; Rats; Receptors, Neuropeptide | 2009 |
Anti-parkinsonian agents procyclidine and ethopropazine alleviate thermal hyperalgesia in neuropathic rats.
Topics: Adrenergic alpha-Agonists; Animals; Antiparkinson Agents; Clonidine; Constriction, Pathologic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Guanabenz; Hyperalgesia; Ligation; Pain Measurement; Peripheral Nervous System Diseases; Phenothiazines; Procyclidine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, N-Methyl-D-Aspartate; Sciatic Nerve | 2003 |